Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX) in a research note issued on Tuesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.

Athersys Stock Performance

The company has a market capitalization of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90. Athersys has a fifty-two week low of $0.01 and a fifty-two week high of $1.99.

Athersys Company Profile

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.